The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Molecular regulation of HDL metabolism and function: implications for novel therapies
Open accessAbstract
HDL biosynthesisApolipoprotein production.The biosynthesis of HDL (Figure 1) is complex and involves the synthesis and secretion of the major protein components of HDL followed by the largely extracellular acquisition of lipid (phospholipids [PLs] and cholesterol) and the assembly and generation of the mature HDL particle.The major HDL apolipoproteins are apoA-I and apoA-II, and both are required for normal HDL biosynthesis.ApoA-I constitutes approximately 70% of HDL protein and is present on virtually all HDL particles (3).Thus, it is not surprising that gene deletion of Apoa1/ APOA1 results in extremely low levels of HDL-C in mice (8) and in humans (9).Atherosclerosis-prone mice lacking apoA-I develop significantly increased atherosclerosis (10).ApoA-I is synthesized in both the intestine and the liver (Figure 1), but the relative contribution of the intestine and the liver to the plasma apoA-I pool in humans remains unknown.Hepatic overex-Molecular regulation of HDL metabolism and function: implications for novel therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,405
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Ross, R., & Glomset, J. A. (1973) · Science · doi:10.1126/science.180.4093.1332 · Cited by 1,501
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,093
Self-citationWang, N., Lan, D., Chen, W., Matsuura, F., & Tall, A. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403506101 · Cited by 1,061
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. M. (1991) · Nature · doi:10.1038/353265a0 · Cited by 986
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 947
Kennedy, M. A., Barrera, G. C., Nakamura, K., Baldán, Á., Tarr, P., Fishbein, M. C., Frank, J., Francone, O. L., & Edwards, P. A. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.002 · Cited by 883
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., & Offermanns, S. (2003) · Nature Medicine · doi:10.1038/nm824 · Cited by 791
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Self-citationOverexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
Kozarsky, K. F., Donahee, M. H., Rigotti, A., Iqbal, S. N., Edelman, E. R., & Krieger, M. (1997) · Nature · doi:10.1038/387414a0 · Cited by 699
Endothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 655
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
CARLSON, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 581
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
McNeish, J., Aiello, R. J., Guyot, D., Turi, T., Gabel, C., Aldinger, C., Hoppe, K. L., Roach, M. L., Royer, L. J., de Wet, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4245 · Cited by 537
Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis?
Cuchel, M., & Rader, D. J. (2006) · Circulation · doi:10.1161/circulationaha.104.475715 · Cited by 527
Self-citationIntestinal ABCA1 directly contributes to HDL biogenesis in vivo
Brunham, L. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27352 · Cited by 519
Trigatti, B., Rayburn, H., Viñals, M., Braun, A., Miettinen, H., Penman, M., Hertz, M., Schrenzel, M., Amigo, L., Rigotti, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9322 · Cited by 504
Cell cholesterol efflux: integration of old and new observations provides new insights
Rothblat, G. H., de la Llera-Moya, M., Atger, V., Kellner-Weibel, G., Williams, D. L., & Phillips, M. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32113-1 · Cited by 503
Braun, A., Trigatti, B. L., Post, M. J., Sato, K., Simons, M., Edelberg, J. M., Rosenberg, R. D., Schrenzel, M., & Krieger, M. (2002) · Circulation Research · doi:10.1161/hh0302.104462 · Cited by 492
Glass, C., Pittman, R. C., Weinstein, D. B., & Steinberg, D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5435 · Cited by 491
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 467
Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis
Martinez, L. O., Jacquet, S., Esteve, J.-P., Rolland, C., Cabezón, E., Champagne, E., Pineau, T., Georgeaud, V., Walker, J. E., Tercé, F., et al. (2003) · Nature · doi:10.1038/nature01250 · Cited by 458
de Grooth, G. J., Kuivenhoven, J. A., Stalenhoef, A. F. H., de Graaf, J., Zwinderman, A. H., Posma, J. L., van Tol, A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000015857.31889.7b · Cited by 456
Timmins, J. M., Lee, J.-Y., Boudyguina, E., Kluckman, K. D., Brunham, L. R., Mulya, A., Gebre, A. K., Coutinho, J. M., Colvin, P. L., Smith, T. L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23915 · Cited by 447
A novel endothelial-derived lipase that modulates HDL metabolism
Jaye, M., Lynch, K. J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., & Rader, D. J. (1999) · Nature Genetics · doi:10.1038/7766 · Cited by 427
Self-citationNavab, M., Anantharamaiah, G. M., Hama, S., Garber, D. W., Chaddha, M., Hough, G., Lallone, R., & Fogelman, A. M. (2002) · Circulation · doi:10.1161/hc0302.103711 · Cited by 401
Jiang, X.-C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., & Tall, A. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5578 · Cited by 394
The liver X receptor gene team: Potential new players in atherosclerosis
Repa, J. J., & Mangelsdorf, D. J. (2002) · Nature Medicine · doi:10.1038/nm1102-1243 · Cited by 388
Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo
Naik, S. U., Wang, X., Da Silva, J. S., Jaye, M., Macphee, C. H., Reilly, M. P., Billheimer, J. T., Rothblat, G. H., & Rader, D. J. (2006) · Circulation · doi:10.1161/circulationaha.105.560177 · Cited by 378
Self-citationClark, R. W., Sutfin, T. A., Ruggeri, R. B., Willauer, A. T., Sugarman, E. D., Magnus-Aryitey, G., Cosgrove, P. G., Sand, T. M., Wester, R. T., Williams, J. A., et al. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118278.21719.17 · Cited by 371
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes
Kuivenhoven, J. A., Pritchard, H., Hill, J., Frohlich, J., Assmann, G., & Kastelein, J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37433-2 · Cited by 367
Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 360
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice
Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D., Puré, E., & Rader, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.17.1816 · Cited by 358
Self-citationPPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis
Li, A. C., & Glass, C. K. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400010-jlr200 · Cited by 357
Kozarsky, K. F., Donahee, M. H., Glick, J. M., Krieger, M., & Rader, D. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.721 · Cited by 337
Self-citationTerasaka, N., Hiroshima, A., Koieyama, T., Ubukata, N., Morikawa, Y., Nakai, D., & Inaba, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03578-0 · Cited by 326
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Hama, S., Hough, G., Grijalva, V. R., Wagner, A. C., Frank, J. S., Datta, G., Garber, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134275.90823.87 · Cited by 323
Arai, T., Wang, N., Bezouevski, M., Welch, C., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2366 · Cited by 312
Endothelial lipase is a major determinant of HDL level
Ishida, T., Choi, S., Kundu, R. K., Hirata, K.-I., Rubin, E. M., Cooper, A. D., & Quertermous, T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16306 · Cited by 306
Cloning of a Unique Lipase from Endothelial Cells Extends the Lipase Gene Family
Hirata, K.-I., Dichek, H. L., Cioffi, J. A., Choi, S. Y., Leeper, N. J., Quintana, L., Kronmal, G. S., Cooper, A. D., & Quertermous, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14170 · Cited by 304
Agellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X. C., Shelanski, S. A., Breslow, J. L., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99088-5 · Cited by 298
Matsuura, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27602 · Cited by 293
Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists
Levin, N., Bischoff, E. D., Daige, C. L., Thomas, D., Vu, C. T., Heyman, R. A., Tangirala, R. K., & Schulman, I. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150044.84012.68 · Cited by 284
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
Schultz, J. R., Verstuyft, J. G., Gong, E. L., Nichols, A. V., & Rubin, E. M. (1993) · Nature · doi:10.1038/365762a0 · Cited by 275
Kozyraki, R., Fyfe, J., Kristiansen, M., Gerdes, C., Jacobsen, C., Cui, S., Christensen, E. I., Aminoff, M., de la Chapelle, A., Krahe, R., et al. (1999) · Nature Medicine · doi:10.1038/9504 · Cited by 273
A review of CETP and its relation to atherosclerosis
de Grooth, G. J., Klerkx, A. H. E. M., Stroes, E. S. G., Stalenhoef, A. F. H., Kastelein, J. J. P., & Kuivenhoven, J. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400007-jlr200 · Cited by 269
Zhang, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25327 · Cited by 267
Control of Cholesterol Turnover in the Mouse
Dietschy, J. M., & Turley, S. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100057200 · Cited by 265
Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels
Haghpassand, M., Bourassa, P.-A. K., Francone, O. L., & Aiello, R. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12810 · Cited by 256
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans
Schwartz, C. C., VandenBroek, J. M., & Cooper, P. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300511-jlr200 · Cited by 249
Berthou, L., Duverger, N., Emmanuel, F., Langouët, S., Auwerx, J., Guillouzo, A., Fruchart, J. C., Rubin, E., Denèfle, P., Staels, B., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118687 · Cited by 248
The impact of phospholipid transfer protein (PLTP) on HDL metabolism
Huuskonen, J., Olkkonen, V. M., Jauhiainen, M., & Ehnholm, C. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00447-6 · Cited by 243
Brousseau, M. E., Diffenderfer, M. R., Millar, J. S., Nartsupha, C., Asztalos, B. F., Welty, F. K., Wolfe, M. L., Rudling, M., Björkhem, I., Angelin, B., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000161928.16334.dd · Cited by 233
Self-citationSchaefer, E. J., Heaton, W. H., Wetzel, M. G., & Brewer, H. B. (1982) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.2.1.16 · Cited by 229
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men
Lamarche, B., Uffelman, K. D., Carpentier, A., Cohn, J. S., Steiner, G., Barrett, P. H., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 229
Eriksson, M., Carlson, L. A., Miettinen, T. A., & Angelin, B. (1999) · Circulation · doi:10.1161/01.cir.100.6.594 · Cited by 228
Curb, J. D., Abbott, R. D., Rodriguez, B. L., Masaki, K., Chen, R., Sharp, D. S., & Tall, A. R. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300520-jlr200 · Cited by 228
Silver, D. L., Wang, N., Xiao, X., & Tall, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101726200 · Cited by 223
Wang, N., Ranalletta, M., Matsuura, F., Peng, F., & Tall, A. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000218998.75963.02 · Cited by 222
Covey, S. D., Krieger, M., Wang, W., Penman, M., & Trigatti, B. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000083343.19940.a0 · Cited by 221
Boekholdt, S. M., Kuivenhoven, J.-A., Wareham, N. J., Peters, R. J. G., Jukema, J. W., Luben, R., Bingham, S. A., Day, N. E., Kastelein, J. J. P., & Khaw, K.-T. (2004) · Circulation · doi:10.1161/01.cir.0000141730.65972.95 · Cited by 218
Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo
Jin, W., Millar, J. S., Broedl, U., Glick, J. M., & Rader, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16146 · Cited by 217
Self-citationZhang, W., Yancey, P. G., Su, Y. R., Babaev, V. R., Zhang, Y., Fazio, S., & Linton, M. F. (2003) · Circulation · doi:10.1161/01.cir.0000093189.97429.9d · Cited by 207
Williamson, R., Lee, D., Hagaman, J., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7134 · Cited by 207
High density lipoprotein receptors, binding proteins, and ligands
Fidge, N. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33357-5 · Cited by 205
Metabolism of High-Density Lipoprotein Apolipoproteins in Tangier Disease
Schaefer, E. J., Blum, C. B., Levy, R. I., Jenkins, L. L., Alaupovic, P., Foster, D. M., & Brewer, H. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810262991701 · Cited by 202
Ma, K., Cilingiroglu, M., Otvos, J. D., Ballantyne, C. M., Marian, A. J., & Chan, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438039100 · Cited by 189
Jiang, X., Francone, O. L., Bruce, C., Milne, R., Mar, J., Walsh, A., Breslow, J. L., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119050 · Cited by 177
Badellino, K. O., Wolfe, M. L., Reilly, M. P., & Rader, D. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030022 · Cited by 173
Self-citationMoore, R. E., Navab, M., Millar, J. S., Zimetti, F., Hama, S., Rothblat, G. H., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000185320.82962.f7 · Cited by 173
Self-citationPutting cholesterol in its place: apoE and reverse cholesterol transport
Mahley, R. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28632 · Cited by 171
Kuivenhoven, J. A., de Grooth, G. J., Kawamura, H., Klerkx, A. H., Wilhelm, F., Trip, M. D., & Kastelein, J. J. P. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.064 · Cited by 170
Ueda, Y., Gong, E., Royer, L., Cooper, P. N., Francone, O. L., & Rubin, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000730200 · Cited by 166
Baldán, A., Pei, L., Lee, R., Tarr, P., Tangirala, R. K., Weinstein, M. M., Frank, J., Li, A. C., Tontonoz, P., & Edwards, P. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000240051.22944.dc · Cited by 166
Van Eck, M., Singaraja, R. R., Ye, D., Hildebrand, R. B., James, E. R., Hayden, M. R., & Van Berkel, T. J. C. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000208364.22732.16 · Cited by 166
Ikewaki, K., Rader, D. J., Sakamoto, T., Nishiwaki, M., Wakimoto, N., Schaefer, J. R., Ishikawa, T., Fairwell, T., Zech, L. A., & Nakamura, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116750 · Cited by 166
Self-citationNiacin therapy in atherosclerosis
Meyers, C. D., Kamanna, V. S., & Kashyap, M. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00006 · Cited by 164
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
Boekholdt, S. M., & Thompson, J. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200018-jlr200 · Cited by 162
Ranalletta, M., Wang, N., Han, S., Yvan‐Charvet, L., Welch, C. L., & Tall, A. R. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242275.92915.43 · Cited by 160
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis
Garber, D. W., Datta, G., Chaddha, M., Palgunachari, M. N., Hama, S. Y., Navab, M., Fogelman, A. M., Segrest, J. P., & Anantharamaiah, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31163-9 · Cited by 157
Hammad, S. M., Stefansson, S., Twal, W. O., Drake, C. J., Fleming, P., Remaley, A. T., Brewer, H. B., & Argraves, W. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10158 · Cited by 156
Protein reabsorption in renal proximal tubule?function and dysfunction in kidney pathophysiology
Christensen, E., & Gburek, J. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1494-0 · Cited by 155
Megalin Acts in Concert with Cubilin to Mediate Endocytosis of High Density Lipoproteins
Hammad, S. M., Barth, J. L., Knaak, C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12003 · Cited by 148
Weng, W., & Breslow, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14788 · Cited by 148
Brundert, M., Ewert, A., Heeren, J., Behrendt, B., Ramakrishnan, R., Greten, H., Merkel, M., & Rinninger, F. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149381.16166.c6 · Cited by 140
Niacin therapy in atherosclerosis
Meyers, C. D., Kamanna, V. S., & Kashyap, M. L. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200502000-00005 · Cited by 139
deLemos, A. S., Wolfe, M. L., Long, C., Sivapackianathan, R., & Rader, D. J. (2002) · Circulation · doi:10.1161/01.cir.0000028423.07623.6a · Cited by 138
Self-citationGenetics of Variation in HDL Cholesterol in Humans and Mice
Wang, X., & Paigen, B. J. (2005) · Circulation Research · doi:10.1161/01.res.0000151332.39871.13 · Cited by 137
Rader, D. J., Ikewaki, K., Duverger, N., Schmidt, H., Pritchard, H., Frohlich, J., Clerc, M., Dumon, M. F., Fairwell, T., & Zech, L. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116962 · Cited by 137
Self-citationEndothelial Lipase Modulates Susceptibility to Atherosclerosis in Apolipoprotein-E-deficient Mice
Ishida, T., Choi, S. Y., Kundu, R. K., Spin, J. M., Yamashita, T., Hirata, K., Kojima, Y., Yokoyama, M., Cooper, A. D., & Quertermous, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406360200 · Cited by 136
Jacquet, S., Malaval, C., Martinez, L. O., Sak, K., Rolland, C., Pérez, C. I., Nauze, M., Champagne, É., Tercé, F., Gachet, C., et al. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5194-0 · Cited by 135
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention
Navab, M., Anantharamaiah, G. M., Reddy, S. T., & Fogelman, A. M. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0661 · Cited by 133
Dose-Dependent Acceleration of High-Density Lipoprotein Catabolism by Endothelial Lipase
Maugeais, C., Tietge, U. J. F., Broedl, U. C., Marchadier, D. H. L., Cain, W. J., McCoy, M. G., Lund‐Katz, S., Glick, J. M., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000092889.24713.dc · Cited by 132
Self-citationThe safety and immunogenicity of a CETP vaccine in healthy adults
Davidson, M. H., Maki, K. C., Umporowicz, D. M., Wheeler, A., Rittershaus, C. W., & Ryan, U. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00137-0 · Cited by 131
Davidson, M. H., McKenney, J. M., Shear, C. L., & Revkin, J. H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.067 · Cited by 129
Ishigami, M., Yamashita, S., Sakai, N., Aral, T., Hirano, K., Hiraoka, H., Kameda-Takemura, K., & Matsuzawa, Y. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124516 · Cited by 128
Toll-Like Receptors, Endocrine Stress Response, and Arteriosclerosis
Bornstein, S. R., & Morawietz, H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178996.91277.fb · Cited by 128
Hayek, T., Chajek‐Shaul, T., Walsh, A., Agellon, L. B., Moulin, P., Tall, A. R., & Breslow, J. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115887 · Cited by 121
Transcriptional Control of Apolipoprotein A-I Gene Expression in Diabetes
Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2004) · Diabetes · doi:10.2337/diabetes.53.3.513 · Cited by 120
石神, 眞. (1996) · Medical Entomology and Zoology · doi:10.11501/3119662 · Cited by 120
Synthetic LXR agonists increase LDL in CETP species
Groot, P. H. E., Pearce, N. J., Yates, J. W., Stocker, C. J., Sauermelch, C. F., Doe, C. P. A., Willette, R. N., Olzinski, A. R., Peters, T., d'Epagnier, D. L., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500116-jlr200 · Cited by 119
Osgood, D. P., Corella, D., Demissie, S., Cupples, L. A., Wilson, P. W. F., Meigs, J. B., Schaefer, E. J., Coltell, Ó., & Ordovás, J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021664 · Cited by 110
Delerive, P., Galardi, C. M., Bisi, J., Nicodème, E., & Goodwin, B. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0132 · Cited by 103
Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans
Nanjee, M. N., Crouse, J. R., King, J. M., Hovorka, R., Rees, S. E., Carson, E. R., Morgenthaler, J. ‐., Lerch, P., & Miller, N. E. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1203 · Cited by 100
The role of the kidney in lipid metabolism
Moestrup, S. K., & Nielsen, L. B. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169350.45944.d4 · Cited by 99
Francone, O. L., Gong, E. L., Ng, D. S., et al. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118180 · Cited by 85
Ikewaki, K., Zech, L. A., Kindt, M. R., Brewer, H. B., & Rader, D. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.3.306 · Cited by 76
Self-citationKo, K. W. S., Paul, A., Ma, K., Li, L., & Chan, L. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500366-jlr200 · Cited by 75
High-Density Lipoproteins as an Emerging Therapeutic Target for Atherosclerosis
Rader, D. J. (2003) · JAMA · doi:10.1001/jama.290.17.2322 · Cited by 60
Self-citationJSchaefer, E., HHeaton, W., GWetzel, M., et al. (1982) · Arteriosclerosis An Official Journal of the American Heart Association Inc · Cited by 59
Focus on high-density lipoproteins in reducing cardiovascular risk
Brewer, H. B. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.04.027 · Cited by 54
Inflammation Warms Up the Metabolic Syndrome
Esposito, K., Ciotola, M., & Giugliano, D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000185830.17528.e3 · Cited by 50
Webb, N. R., de Beer, M. C., Yu, J., Kindy, M. S., Daugherty, A., van der Westhuyzen, D. R., & de Beer, F. C. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200026-jlr200 · Cited by 40
Insight into the Role of LCAT from Mouse Models
Ng, D. S. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000045102.70521.af · Cited by 33
Torcetrapib/atorvastatin combination therapy
Bays, H. E., McKenney, J. M., & Davidson, M. H. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.789 · Cited by 28
Rader, D. J. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0052-3 · Cited by 27
Self-citation
Cited by
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942
Pathophysiology of diabetic dyslipidaemia: where are we?
Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708
Macrophage phenotypes in atherosclerosis
Colin, S., Chinetti‐Gbaguidi, G., & Staels, B. (2014) · Immunological Reviews · doi:10.1111/imr.12218 · Cited by 657
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Rader, D. J., Alexander, E. T., Weibel, G. L., Billheimer, J., & Rothblat, G. H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800088-jlr200 · Cited by 597
Self-citation
Metadata
- Authors
- Rader, D. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-12-01
- Volume
- 116
- Issue
- 12
- Pages
- 3090-3100
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1968196140
- Cited by
- 599
- References
- 131
- FWCI
- 51.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.